Reduce

17-4-2018

Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice

One way FDA oversees food safety is through monitoring of contaminants in food, such as arsenic, assessing potential exposure and taking steps to reduce exposure

FDA - U.S. Food and Drug Administration

23-3-2018

Consumption of wild game: action needed to reduce exposure to chemical contaminants, and to lead in particular

Today the Agency is publishing the results of its expert appraisal on the health risks associated with the consumption of wild game and the environmental chemical contaminants (dioxins, polychlorinated biphenyls - PCBs, cadmium and lead) found in both wild and farmed game. While game can be contaminated by numerous chemicals present in its living environment or via ammunition, the available data only give a partial picture of wild game contamination in France.

France - Agence Nationale du Médicament Vétérinaire

20-3-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products

FDA takes steps to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products.

FDA - U.S. Food and Drug Administration

15-3-2018

Statement from FDA Commissioner Scott Gottlieb, M.D., on pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels

FDA takes pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels.

FDA - U.S. Food and Drug Administration

26-2-2018

FDA Drug Safety Communication: FDA requires label warnings to prohibit sharing of multi-dose diabetes pen devices among patients

[2-25-2015] In an effort to reduce the serious risk of infection spread through sharing of multi-dose diabetes pen devices intended for single patient use only, the U.S. Food and Drug Administration (FDA) is requiring additional label warnings prohibiting sharing of these injectable medicines.

FDA - U.S. Food and Drug Administration

16-2-2018

FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing

FDA approves drug to reduce the risk of stage III non-small cell lung cancer progressing

FDA - U.S. Food and Drug Administration

14-2-2018

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults

FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults; new quick testing option to help reduce need for CT scans, radiation exposure for patients

FDA - U.S. Food and Drug Administration

9-2-2018

Alysena 28 birth control pill: One lot recalled due to chipped pills, which may reduce effectiveness in preventing pregnancy

Health Canada is advising Canadians that Apotex Inc. is voluntarily recalling one lot of Alysena 28 birth control pill (lot LF10133A) after complaints about chipped pink pills in sealed blister packages.

Health Canada

7-2-2018

Pentax Medical Duodenoscope Model ED-3490TK: FDA Safety Communication - Updated Design and Labeling Cleared

Design changes are intended to reduce the potential for leakage of patient fluids into the closed elevator channel and under the distal cap.

FDA - U.S. Food and Drug Administration

24-1-2018

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote reduction, refinement and replacement (3Rs) measures described in the European Pharmacopoeia - Applicable to veterina

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph. Eur.) has, over the years, applied these principles by implementing alternative tests and assays that reduce, refine and replace animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

24-1-2018

Scientific guideline: Recommendation to marketing authorisation holders, highlighting recent measures in the veterinary field to promote replacement, reduction, and refinement (3Rs) measures described in the European Pharmacopoeia - Applicable to human v

In accordance with the European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes (Council of Europe), tests performed in animals must be carried out in such a way as to use the minimum number of animals and to cause the least pain, suffering, distress or lasting harm. The European Pharmacopeia (Ph.Eur.) has, over the years, applied these principles by implementing alternative tests and assays that replace, reduce and refine animal use.

Europe - EFSA - European Food Safety Authority EFSA Journal

8-12-2017

Food supplements for developing muscle or reducing body fat

The national nutrivigilance scheme has collected several reports of adverse effects likely to be associated with the consumption of food supplements for athletes seeking to develop muscle or reduce body fat. These reports, and the widespread consumption of these types of products in several sports disciplines, have led ANSES to draw attention to the potential health risks. Effects that are potentially serious, primarily cardiovascular (tachycardia, arrhythmia and stroke) and psychological (anxiety and mo...

France - Agence Nationale du Médicament Vétérinaire

1-12-2017

Alesse 21 and 28 birth control pill: Packages may contain broken or smaller-than-normal pills, which may reduce effectiveness in preventing pregnancy

Health Canada is advising consumers and health care professionals that complaints have been received for packages of Alesse 21 (21 active pills) and Alesse 28 (21 active pills, 7 that contain no hormones). The blister packages for both contained an active (pink) pill that was roughly half the proper size.

Health Canada

27-11-2017

Facilitating the marketing of biocontrol plant protection products

Biocontrol is one of the solutions that could facilitate the substitution of synthetic plant protection products by non-chemical alternatives, with a view to achieving the goals of the French Ecophyto 2018 plan to reduce pesticide use. Although they are of natural origin, these plant protection products still have to be scientifically assessed, in terms of their effectiveness and their safety to health and the environment, before they can be placed on the market. ANSES has set up a specific system to giv...

France - Agence Nationale du Médicament Vétérinaire

24-11-2017

Guidance for Industry: Recommendations for Donor Questioning, Deferral, Reentry and Product Management to Reduce the Risk of Transfusion-Transmitted Malaria

FDA - U.S. Food and Drug Administration

16-11-2017

FDA expands approval of Sutent to reduce the risk of kidney cancer returning

FDA approves first adjuvant treatment for adult patients who are at a high risk of kidney cancer returning after a kidney has been removed.

FDA - U.S. Food and Drug Administration

16-11-2017

FDA approves new treatment to prevent bleeding in certain patients with hemophilia A

FDA approves new treatment to prevent or reduce frequency of bleeding episodes in patients with hemophilia A who have Factor VIII inhibitors.

FDA - U.S. Food and Drug Administration

15-11-2017

FDA grants marketing authorization of the first device for use in helping to reduce the symptoms of opioid withdrawal

FDA permits marketing of the first device for use in helping to reduce the symptoms of opioid withdrawal

FDA - U.S. Food and Drug Administration

14-11-2017

Health Canada takes steps to help Canadians avoid rare risk of liver injury from use of green tea extract health products

OTTAWA – Health Canada has completed a safety review of green tea extract in natural health products and, as a result, is strengthening the warnings on labels of these products to help reduce the risk of liver injury.

Health Canada

12-10-2017

Potential alternatives to bisphenol A

Its different expert appraisal work on the health risks associated with exposure to bisphenol A has led ANSES to conclude that there are sufficient scientific data to consider it a priority to reduce exposure of the most vulnerable populations: infants, young children, pregnant and breastfeeding women. Since January 2015, for example, bisphenol A has been prohibited in food containers placed on the market in France. It is therefore necessary to find alternatives to bisphenol A.  Language English

France - Agence Nationale du Médicament Vétérinaire

20-9-2017

FDA Drug Safety Communication: FDA urges caution about withholding opioid addiction medications from patients taking benzodiazepines or CNS depressants: careful medication management can reduce risks

Based on our additional review, the U.S. Food and Drug Administration (FDA) is advising that the opioid addiction medications buprenorphine and methadone should not be withheld from patients taking benzodiazepines or other drugs that depress the central nervous system (CNS). The combined use of these drugs increases the risk of serious side effects; however, the harm caused by untreated opioid addiction usually outweighs these risks. Careful medication management by health care professionals can reduce...

FDA - U.S. Food and Drug Administration

20-9-2017

Opioid Addiction Medications in Patients Taking Benzodiazepines or CNS Depressants: Drug Safety Communication - Careful Medication Management Can Reduce Risks

Health care professionals should develop a treatment plan when buprenorphine or methadone is used in combination with benzodiazepines or other CNS depressants.

FDA - U.S. Food and Drug Administration

11-9-2017

DKMA Update

Our newsletter Danish Pharmacovigilance Update changes name to DKMA Update and will from now on contain information about medicinal products in general, patient safety and life science. DKMA Update is an electronic newsletter intended for anyone who work with medicines, either clinically or in the pharmaceutical industry or the retail industry, and people who would like to gain an insight into our work. The newsletter will continue to focus on the most recent safety updates, but will also focus on other...

Danish Medicines Agency

7-9-2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy

Statement from FDA Commissioner Scott Gottlieb, M.D., on a new qualified health claim advising that early introduction of peanuts to certain high-risk infants may reduce risk of peanut allergy

FDA - U.S. Food and Drug Administration

29-3-2018

Katie also works with stakeholders to improve diverse clinical study participation and resulting scientific evidence to reduce healthcare disparities #WomensHistoryMonthpic.twitter.com/N1wQJ5h0Ab

Katie also works with stakeholders to improve diverse clinical study participation and resulting scientific evidence to reduce healthcare disparities #WomensHistoryMonth pic.twitter.com/N1wQJ5h0Ab

FDA - U.S. Food and Drug Administration

27-3-2018

Health Tip: Ways to Reduce Stress

Title: Health Tip: Ways to Reduce StressCategory: Health NewsCreated: 3/26/2018 12:00:00 AMLast Editorial Review: 3/26/2018 12:00:00 AM

US - MedicineNet

19-3-2018

Bentyl vs. Levsin

Bentyl (dicyclomine) and Levsin (hyoscyamine) are anticholinergics prescribed for irritable bowel syndrome (IBS). Levsin is also used to treat different stomach and intestinal disorders, including peptic ulcer. Levsin is also used to control muscle spasms in the bladder, kidneys, or digestive tract, and to reduce stomach acid. Levsin is sometimes used to reduce tremors and rigid muscles in people with symptoms of Parkinson's disease, and is also used as a drying agent to control excessive salivation, run...

US - RxList

6-3-2018

Boosting Steroid Dose May Not Reduce Kids' Asthma Flare-Ups

Title: Boosting Steroid Dose May Not Reduce Kids' Asthma Flare-UpsCategory: Health NewsCreated: 3/3/2018 12:00:00 AMLast Editorial Review: 3/5/2018 12:00:00 AM

US - MedicineNet

26-2-2018

News and press releases: Towards more ethical use of animals in medicine testing

First report on EMA’s actions to replace, reduce, refine use of animals in medical research

Europe - EMA - European Medicines Agency

16-2-2018

News and press releases: Committee for Medicinal Products for Veterinary Use (CVMP) meeting of 13-15 February 2018

CVMP recommends changes to product information for some veterinary medicines containing enrofloxacin, to reduce development of antimicrobial resistance in target pathogens

Europe - EMA - European Medicines Agency

14-2-2018

FDA authorizes marketing of 1st blood test to aid in eval of concussion in adults. Most patients eval'd for concussion w/ a CT scan don't have detectable brain tissue damage. This quick testing option helps reduce the need for CT scans, radiation exposure

FDA authorizes marketing of 1st blood test to aid in eval of concussion in adults. Most patients eval'd for concussion w/ a CT scan don't have detectable brain tissue damage. This quick testing option helps reduce the need for CT scans, radiation exposure https://go.usa.gov/xn6vh  pic.twitter.com/QQzznfsvmI

FDA - U.S. Food and Drug Administration

6-2-2018

Crestor vs. Livalo

Crestor (rosuvastatin calcium) and Livalo (pitavastatin) are statin drugs that work by slowing the production of cholesterol by the body, used to lower cholesterol and fats (triglycerides) in the blood which can reduce the chances of developing problems such as heart disease and strokes.

US - RxList

6-2-2018

Crestor vs. Pravachol

Crestor (rosuvastatin calcium) and Pravachol (pravastatin) statin drugs that work by slowing the production of cholesterol by the body, used to lower cholesterol and fats (triglycerides) in the blood which can reduce the chances of developing problems such as heart disease and strokes that can be caused, in part, by high cholesterol levels.

US - RxList

6-2-2018

Crestor vs. Zetia

Crestor (rosuvastatin calcium) and Zetia (ezetimibe) are drugs used to lower cholesterol and fats (triglycerides) in the blood which can reduce the chances of developing problems such as heart disease and strokes that can be caused, in part, by high cholesterol levels. Crestor and Zetia belong to different drug classes

US - RxList

31-1-2018

ACA Mandate Repeal, Drug Prices, Opioids in State of the Union

In his first State of the Union address tonight, President Donald J. Trump said he would work to reduce prescription drug prices, urged Congress to pass a "right-to-try" law, and applauded the elimination of the Affordable Care Act requirement that individuals purchase insurance. He also highlighted the need to take action on the opioid crisis.

US - RxList

31-1-2018

Lasix vs. Aldactone

Lasix (furosemide) and Aldactone (spironolactone) are used to reduce edema (fluid accumulation) caused by heart, liver or kidney problems, or high blood pressure (hypertension). Lasix may also be used with antihypertensive drugs to control high blood pressure hypertension). Aldactone is also used to reduce edema caused by certain patients with hyperaldosteronism. Lasix and Aldactone belong to different drug classes. Lasix is an anthranilic acid derivative used as a strong loop diuretic and Aldactone is ...

US - RxList

29-1-2018

Leflunomide (Arava)

Leflunomide is a pyrimidine synthesis inhibitor belonging to the disease-modifying anti-rheumatic class of drugs (DMARD) used to treat symptoms of rheumatoid arthritis. Leflunomide also helps reduce joint damage and improves physical functioning.

US - RxList

27-1-2018

Pill Combo May Do More to Reduce Stroke Risk

Title: Pill Combo May Do More to Reduce Stroke RiskCategory: Health NewsCreated: 1/25/2018 12:00:00 AMLast Editorial Review: 1/26/2018 12:00:00 AM

US - MedicineNet

26-1-2018

Octreotide

Octreotide is used to treat severe watery diarrhea and sudden reddening of the face and neck caused by certain types of tumors (e.g., carcinoid tumors, vasoactive intestinal peptide tumors) that are found usually in the intestines and pancreas. The symptoms occur when these tumors make too much of certain natural substances (hormones). This medication works by blocking the production of these hormones. By decreasing watery diarrhea, octreotide helps to reduce the loss of body fluids and minerals.

US - RxList

26-1-2018

Minocycline

Minocycline is used to treat moderate to severe acne in people 12 years and older. It helps to reduce the number of pimples. Minocycline belongs to a class of drugs known as tetracycline antibiotics. It works by stopping the growth of bacteria that may make acne worse.

US - RxList

25-1-2018

Smoking Even One Cigarette a Day Raises Cardiovascular Risk

For people who think that smoking only one or two cigarettes a day carries little cardiovascular risk, a powerful new study maintains the only way to reduce risk is to quit, full stop

US - RxList

23-1-2018

Rivaroxaban

Rivaroxaban is a prescription medicine used to reduce the risk of stroke and blood clots in people with atrial fibrillation, not caused by a heart valve problem. Rivaroxaban is also used to treat deep vein thrombosis and pulmonary embolism, and to help reduce the risk of these conditions occurring again, and to reduce the risk of forming a blood clot in the legs and lungs of people who have just had knee or hip replacement surgery. Rivaroxaban is available under the following different brand names: Xarel...

US - RxList

19-1-2018

Reduce Legal Blood-Alcohol Limit to Cut Drunk Driving Deaths: Report

Title: Reduce Legal Blood-Alcohol Limit to Cut Drunk Driving Deaths: ReportCategory: Health NewsCreated: 1/17/2018 12:00:00 AMLast Editorial Review: 1/18/2018 12:00:00 AM

US - MedicineNet

19-1-2018

Rabeprazole

Rabeprazole is a proton pump inhibitor (PPI) to reduce stomach acid and is used for the treatment of gastroesophageal reflux disease (GERD), duodenal ulcers, and used in combination with antibiotics to treat Helicobacter pylori (H. pylori) bacterial infections in the stomach.

US - RxList

17-1-2018

Omega 3 Fatty Acids

Omega 3 fatty acids are a lipid-regulating agent used as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe (500 mg/dL or greater) hypertriglyceridemia.

US - RxList

11-1-2018

Ibuprofen (Advil, Motrin)

Ibuprofen is a pain reliever and fever reducer used to temporarily relieve minor aches and pains due to headache, toothache, backache, menstrual cramps, the common cold, muscular aches, and minor pain of arthritis. Ibuprofen is also used to temporarily reduce fever.

US - RxList

8-1-2018

Glycopyrrolate

Glycopyrrolate is an anticholinergic that helps to control conditions such as peptic ulcers that involve excessive stomach acid production. The injectable form of glycopyrrolate is also used to reduce saliva, nasal, lung, and stomach secretions and to help control heart rate during surgery.

US - RxList

3-1-2018

Methylprednisolone

Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone.

US - RxList

27-12-2017

5 Ways to Reduce Saturated Fat

Title: 5 Ways to Reduce Saturated FatCategory: Health NewsCreated: 12/26/2017 12:00:00 AMLast Editorial Review: 12/26/2017 12:00:00 AM

US - MedicineNet

19-12-2017

Lipitor vs. Crestor

Lipitor (atorvastatin) and Crestor (rosuvastatin calcium) are statin drugs used for the treatment of elevated total cholesterol, LDL, fats (triglycerides), and to elevate HDL cholesterol, to reduce the chances of developing problems such as heart disease and strokes that can be caused, in part, by high cholesterol levels.

US - RxList

19-12-2017

Lipitor vs. Pravachol

Lipitor (atorvastatin) and Pravachol (pravastatin) are statin drugs used for the treatment of elevated total cholesterol, LDL, fats (triglycerides), and to elevate HDL cholesterol, and reduce the risk of heart attack, stroke, and death due to arteriosclerotic vascular disease.

US - RxList

7-12-2017

CGM May Improve Hypoglycemia Awareness in Type 1 Diabetes

Continuous glucose monitoring (CGM) may improve awareness and reduce the risk for severe hypoglycemia in patients with longstanding type 1 diabetes.

US - RxList

6-12-2017

Zyprexa vs. Clozaril

Zyprexa (olanzapine) and Clozaril (clozapine) are antipsychotic medications used to treat schizophrenia. A difference is Zyprexa is also used to treat manic episodes of bipolar disorder. Clozaril is also used to help reduce the risk of suicidal behavior in people with schizophrenia or similar disorders.

US - RxList

15-11-2017

FDA Grants Marketing of the First Device Helping to Reduce the Symptoms of Opioid Withdrawal

Today, the U.S. Food and Drug Administration granted a new indication to an electric stimulation device for use in helping to reduce the symptoms of opioid withdrawal.

US - RxList

10-11-2017

News and press releases: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage

Zinbryta to be used in restricted patient group, with strict liver monitoring

Europe - EMA - European Medicines Agency

10-11-2017

Pradaxa vs. Coumadin

Pradaxa (dabigatran) and Coumadin (warfarin) are anticoagulants used to prevent blood clots to reduce or prevent the chance of developing heart attacks (myocardial infarctions), strokes, and venous and other blood clots (deep venous thromboses, pulmonary emboli and thrombi produced with atrial fibrillation). They are also used to treat these conditions if they develop.

US - RxList

9-11-2017

New Guidelines for Allergic Rhinitis Change Treatment

An update of recommendations for the treatment of seasonal allergic rhinitis (SAR) in adolescents and adults, issued by members of the Joint Task Force on Practice Parameters (JTFPP), changes initial treatment strategies and aims to reduce unnecessary cost to patients and variations in care.

US - RxList

25-10-2017

Tamoxifen

Tamoxifen is used to treat breast cancer that has spread to other parts of the body (metastatic breast cancer), to treat breast cancer in certain patients after surgery and radiation therapy, and to reduce the chances of breast cancer in high-risk patients.

US - RxList

24-10-2017

Reduce #SIDS & #suffocation risk. Always put baby on back to sleep with no soft objects in sleep area. #SafetoSleep http://thndr.me/W3Dyab pic.twitter.com/myDGKnsFzZ

Reduce #SIDS & #suffocation risk. Always put baby on back to sleep with no soft objects in sleep area. #SafetoSleep http://thndr.me/W3Dyab  pic.twitter.com/myDGKnsFzZ

FDA - U.S. Food and Drug Administration

24-10-2017

Surgery Process Maps May Reduces Infection Risks in Low Resource Settings

SAN DIEGO — Process maps can reduce the risk for perioperative infection in low-income countries by pinpointing barriers to good procedures, researchers say.

US - RxList

22-10-2017

You can reduce your baby’s risk of #SIDS & other sleep-related causes of infant death. Take action. http://bit.ly/2qcVb8u  #SafeToSleeppic.twitter.com/nRSBCwCYeb

You can reduce your baby’s risk of #SIDS & other sleep-related causes of infant death. Take action. http://bit.ly/2qcVb8u  #SafeToSleep pic.twitter.com/nRSBCwCYeb

FDA - U.S. Food and Drug Administration

10-10-2017

Brilinta vs. Plavix

Brilinta (ticagrelor) and Plavix (clopidogrel bisulfate) are both blood-thinners used to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS), peripheral vascular disease, and ischemic strokes.

US - RxList

26-9-2017

News and press releases: EMA’s first public hearing: giving EU citizens a voice to help reduce the risk of valproate

Live broadcast on 26 September from 12:45 to 18:00 UK time

Europe - EMA - European Medicines Agency

7-9-2017

Whole Grains and Exercise Curb Risk for Colorectal Cancer

Eating whole grains daily and ramping up activity levels can reduce the risk for colorectal/colon cancer, according to a new report from the American Institute for Cancer Research (AICR) and the World Cancer Research Fund (WCRF). On the flipside, consuming red meat and processed meat increases the risk, as does drinking two or more alcoholic beverages per day.

US - RxList